2030 Courses delivered Online

GDPR, Legal Advisor & Office Management- QLS Endorsed

4.8(12)

By Academy for Health and Fitness

GDPR, Legal Advisor & Office Management- QLS Endorsed
Delivered Online On Demand36 hours
£309

Solicitor, Legal Advisor & Conveyancing

4.8(12)

By Academy for Health and Fitness

Solicitor, Legal Advisor & Conveyancing
Delivered Online On Demand34 hours
£309

Logistic, Retail & Supply Chain Management

4.8(12)

By Academy for Health and Fitness

Logistic, Retail & Supply Chain Management
Delivered Online On Demand48 hours
£309

DIPLOMA IN GAME DESIGN AND DEVELOPMENT One to One Online or Face to Face

By Real Animation Works

Face to face training customised and bespoke. Professional tutors. One to One Online or Face to Face

DIPLOMA IN GAME DESIGN AND DEVELOPMENT One to One Online or Face to Face
Delivered in London or OnlineFlexible Dates
£4000

Diploma in Architecture and Interior Design Diploma 1-2-1

By Real Animation Works

Face to face One to one.

Diploma in Architecture and Interior Design Diploma 1-2-1
Delivered in Internationally or OnlineFlexible Dates
£4000

Assuring Quality Through Acceptance Testing: In-House Training

By IIL Europe Ltd

Assuring Quality Through Acceptance Testing: In-House Training
Delivered in London or UK Wide or OnlineFlexible Dates
£1495

Arbitration and Dispute Resolution

By EMG Associates UK Limited

Arbitration and Dispute Resolution
Delivered OnlineFlexible Dates
£2964

Logistics Manager - QLS Endorsed Bundle

By Imperial Academy

10 QLS Endorsed Courses for Logistics Manager | 10 Endorsed Certificates Included | Life Time Access

Logistics Manager - QLS Endorsed Bundle
Delivered Online On Demand
£599

CARGO SURVEYING ADVANCED DIPLOMA EXPERT IN DRAUGHT SURVEYING

By Lloyd's Maritime Institute

https://www.lloydmaritime.com/C-S/cargo-surveying-advanced-diploma-expert-in-draught-surveying

CARGO SURVEYING ADVANCED DIPLOMA EXPERT IN DRAUGHT SURVEYING
Delivered Online On Demand
£600

SUB01: Orphan Drug Designation in the USA and Europe

By Zenosis

Medicines for the prevention, diagnosis, or treatment of rare diseases have become known as ‘orphan drugs’ because of their commercial unattractiveness. Development of such products is successfully encouraged through incentives offered by regulatory authorities. To qualify for important incentives, the sponsor of a drug must gain ‘orphan designation’ for its use in an indication. This module describes the requirements for orphan designation and how to apply for it in the USA and the European Economic Area.

SUB01: Orphan Drug Designation in the USA and Europe
Delivered Online On Demand1 hour 30 minutes
£74